Log in
This Keele University research into advanced signal processing and classification methods has led to novel algorithms capable of isolating subtle patterns in complex data. This has been applied in two highly significant application areas: first to the problem of image source identification and second to the problem of unobtrusive but highly secure authentication methods. In the first case this has enabled images captured by mobile phone cameras to be reliably and evidentially linked to source devices. This has huge applicability to those fighting terrorism, paedophile rings and civil unrest by extending detection capabilities to mobile phones in an era in which they are rapidly replacing dedicated cameras. It helps to prove, for example, that a photograph entered as evidence was captured by a specific mobile phone. As most phones can be tied to their user or owner this is extremely important to the successful detection and prosecution of offenders.
In the second case it has enabled criminal record checks to be carried out securely online where previous paper-based systems were both too slow for purpose (taking weeks or months) and inherently insecure, leaving key posts unfilled in the health care industries and education sector; so benefitting the public by solving a problem that was having a negative impact on the running of these public services.
Research (1993-2008) on novel silicon architectures and design methodologies for digital signal and video processing led to the creation of world leading semiconductor IP cores (chip designs) for implementing the main video and image compression standards including H.264, MPEG4, MPEG2, and JPEG2000. These have been licensed to semiconductor manufacturers worldwide including Panasonic, Sony, Toshiba and Sharp. Since 2008, such encoders/decoders have been incorporated into all DTV/HDTV SoCs produced by Conexant, NXP, Trident Microsystems and Entropic. They have also been used as the hardware acceleration engines in Intel's C2110 Media Processor. At least 150 million chips worldwide having been manufactured incorporating this technology.
DualEELS™ is a recent advance in Electron Energy Loss Spectroscopy (EELS) made possible by a successful collaboration between the University of Glasgow and Gatan, the world leader in electron spectroscopy systems for electron microscopy. The resulting Gatan GIF QUANTUM® and the ENFINIUM® electron microscope products, incorporating the novel DualEELS™ concept pioneered in Glasgow, have been a commercial success. Between the launch in 2009 and the end of 2011, 145 systems have been delivered to universities, research institutes and industry at a total market value of over US$7.5M. The market penetration of the DualEELS™ technique has been very high. In 2012, DualEELS™ units were delivered with over 70% of all GIF/EELS systems sold. These systems are used routinely for R&D, quality control and failure analysis in firms such as AMD, Intel and Samsung, and for development of the advanced materials and devices key to modern society in a wide range of industrial sectors.
Two decades of radar research at The University of Birmingham have had profound impacts on automotive radar systems. This is demonstrated by specific Jaguar LandRover products: adaptive cruise control (ACC); blind spot monitoring; and lane change merge aid. The first two of these are now available across the Jaguar and Land Rover ranges while the third is ready for launch in 2014. Wider economic and road safety impacts are occurring as the technology cascades down from the luxury vehicle market and achieves wider adoption. Automotive radar makes a significant financial contribution to Jaguar LandRover (JLR). Birmingham research has been vital to the development of this industry, in establishing fundamental scientific feasibility and technological viability and in solving deep technical challenges.
A software package called CPO has been developed that simulates the motion of charged particles in electromagnetic fields. More than 200 benchmark tests have established CPO as the gold standard in low-energy charged-particle optics. A spin-off company was formed to market CPO, [text removed for publication]
Practical Waveform Engineering, developed at Cardiff, is having a major impact on how modern- day microwave power amplifiers are designed, delivering real competitive advantages for global communications companies such as Nokia-Siemens-Networks and M/A-COM.
Economic impact is through reduced time-to-market and lower design costs, leading to high- performance power amplifier products. Examples include $40M revenue and employment of additional staff for M/A-Com, and the successful spin-off company Mesuro Ltd., generating revenue in excess of £2.5M.
Impact on practice is through successful demonstration of new device technologies and amplifier architectures, the introduction of PWE-based CAD models, and most significantly, the introduction of the "Cardiff Model" into mainstream simulation tools.
Environmental Impact is by improving the efficiency of power amplifiers and significantly reducing the carbon contribution of mobile communications systems, translating into savings of approximately £2.5M/year and a 17 kiloton reduction in CO2 emission for a typical EU network.
Research at the University of Manchester has led to the provision of cost effective instruments for monitoring water, industrial and environmental pollution. The underpinning research on chemical sensors conducted in the unit was protected by patent, and in 2007 Multisensor Systems Ltd was spun-out in-order to meet the needs of the water industry and has grown to employ 6 people in 2013. Currently this is the only commercially available instrument sensitive enough to monitor low concentrations of hydrocarbon pollution and is used by major UK water companies to prevent risk of environmental pollution hazards with mitigated losses valued at more than £100m.
This University of Manchester research underpins UK industry's global position in millimetre- wave imaging and ultra-high-precision sensing. These are key technologies in a range of industrial, medical and consumer electronics applications. The devices and methods developed by the research team are now used by a range of companies leading to economic impacts for the UK in strong export markets. In this case study we provide examples of impacts that support commercial sales in excess of £300m by UK SME and FTSE-listed companies in three sectors: automotive radar (e2v), terahertz imaging (TeraView), and linear encoders (Renishaw PLC).
A new product has been developed to aid marine navigation and berthing at ports, based on the use of a single-sideband (SSB) active target, offering the dual benefits of substantially enhanced performance, and reduced size and production costs. The research has achieved significant commercial impact via the incorporation of the technique, conceived by Brennan, into all such targets made by Guidance Microwave Ltd, a UK-based engineering company specialising in the development, manufacture and supply of short-range active target location systems. To date, the company has sold approximately 700 active targets (around 25 per month), generating more than £3 million in sales. The idea (subject to patent protection) was initially incorporated in the mini-Radascan product, which is now a valuable tool to the industry and has given Guidance Microwave Ltd. a competitive advantage, becoming their most successful product.
This case study outlines the impact in generating investment in a spin-out SME and in developing a technology for clinical diagnosis based on chemistry research carried out in Bath. The research led to a spin-out company, Atlas Genetics, which has raised over £18M funding in the REF period specifically to develop the Atlas io™ platform, novel technology for rapid (<30 minute) and robust detection of infectious diseases suitable for point-of-care. The investment has created new jobs for highly skilled workers at the cutting-edge of medical diagnostics, with Atlas currently employing 36 staff. The io™ platform has been fully developed and has undergone successful clinical tests on multiple infections (based on bespoke Chemistry developed at Bath) prior to clinical trialling and rollout in Europe and the United States.